Following the installation of eProtein Discovery at leading academic institutes across the UK and Europe 1, the expansion ...

Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...

Baculovirus expression systems have emerged as an indispensable tool in the production of recombinant proteins, offering a robust platform for achieving high-level expression in insect cells. By ...

Escherichia coli remains at the forefront of recombinant protein production, owing to its rapid growth, well-characterised genetics and the ease with which it can be genetically manipulated. The ...

This comprehensive report provides an insightful overview of the global protein expression market, highlighting key market trends and revenue projections. It offers detailed data ...

The cost-effective, easy-to-use T7 expression system has been integral to Escherichia coli protein production since its introduction in 1986. Now, a just-developed enhancement is making it even better ...

CARMIEL, Israel, May 29, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic ...

Making proteins for research or therapies often starts with cell-line development. In many applications, genetic engineering is used to optimize a cell line for producing high levels of the intended ...

CARMIEL, Israel, May 9, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic ...

The funding will support further development of eProtein Discovery to enable full-format antibody expression, purification, ...